, Your Membrane Proteins are Showing

For those who need to express recombinant membrane proteins, the use of Escherichia coli has been problematic because these proteins are often lethal, according to Mary Lynne Collins, a professor of biology at the University of Wisconsin, Milwaukee. Collins and Yongjian Cheng were recently awarded US patent 6,680,179 for a method that allows expression of membrane proteins in Rhodospirillum rubrum, whose unique features make it an attractive host, says Collins.R. rubrum is a photosynthetic bacte

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

For those who need to express recombinant membrane proteins, the use of Escherichia coli has been problematic because these proteins are often lethal, according to Mary Lynne Collins, a professor of biology at the University of Wisconsin, Milwaukee. Collins and Yongjian Cheng were recently awarded US patent 6,680,179 for a method that allows expression of membrane proteins in Rhodospirillum rubrum, whose unique features make it an attractive host, says Collins.

R. rubrum is a photosynthetic bacterium that, under certain conditions, forms an intracytoplasmic membrane (ICM) that is not essential for growth. The ICM comprises mostly photochemical components. "Our knockout mutants lack the photochemical components and do not form ICM but retain the capacity to do so," says Collins. "This provides excess capacity for membrane formation that can accommodate heterologous proteins. Expressed proteins are assembled in the ICM. Separation of the ICM from the other cellular material can facilitate recovery of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies